Found: 26
Select item for more details and to access through your institution.
Editorial: proton pump inhibitor therapy and liver disease progression-more cause for concern?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 192, doi. 10.1111/apt.14397
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 159, doi. 10.1111/apt.14296
- Publication type:
- Article
Editorial: non-alcoholic fatty liver disease-it is better to be slender after all.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: hepatocellular carcinoma risk in the era of direct-acting anti-virals-is the case closed?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 279, doi. 10.1111/apt.14388
- By:
- Publication type:
- Article
Randomised clinical trial: yoga vs a low- FODMAP diet in patients with irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 203, doi. 10.1111/apt.14400
- By:
- Publication type:
- Article
Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis? Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: monitoring blood pressure is key to the safe use of beta-blockers in patients with chronic liver failure.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 219, doi. 10.1111/apt.14420
- By:
- Publication type:
- Article
Editorial: rifaximin-a kick in the gut for spontaneous bacterial peritonitis?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 229, doi. 10.1111/apt.14421
- By:
- Publication type:
- Article
Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 162, doi. 10.1111/apt.14422
- By:
- Publication type:
- Article
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 259, doi. 10.1111/apt.14423
- By:
- Publication type:
- Article
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation-Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 312, doi. 10.1111/apt.14446
- By:
- Publication type:
- Article
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 310, doi. 10.1111/apt.14425
- By:
- Publication type:
- Article
Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD-Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 246, doi. 10.1111/apt.14391
- By:
- Publication type:
- Article
Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC- IBD patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 238, doi. 10.1111/apt.14393
- By:
- Publication type:
- Article
Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 212, doi. 10.1111/apt.14410
- By:
- Publication type:
- Article
Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 268, doi. 10.1111/apt.14411
- By:
- Publication type:
- Article
Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 176, doi. 10.1111/apt.14416
- By:
- Publication type:
- Article
Editorial: the IBD-disability index-ready for prime time?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Genetic risk factors for perception of symptoms in GERD: an observational cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 289, doi. 10.1111/apt.14414
- By:
- Publication type:
- Article